We recently published a list of Why These 10 Firms Recorded Double-Digit Gains Last Week. In this article, we are going to ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.

Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...

We recently published a list of These 10 Firms Topped Wednesday’s Trading. In this article, we are going to take a look at ...

Tempus AI Inc (NASDAQ:TEM) shares closed up 14.5% following the announcement of expanded strategic partnerships with ...

Many of America’s wealthiest business leaders have lost millions — if not billions — of dollars in net worth since the start of the year, as President Donald Trump’s policies hit markets. But some ...

Tempus stands to earn $200 million in data licensing and model development fees from the collaborations, the release said.

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ...

Chuck Davis, Mark Zuckerberg, Jamie Dimon, and Max de Groen were among other top executives who sold their stake in their ...

8. Eric Lefkofsky Chairman & CEO, Tempus AI Inc. Total shares sold: 4,052,579 Total value sold: US$231,462,927 The co-founder ...

Cohen’s personal worth now sits at $3.3 billion, most of it tied to Denver-based Palantir options. Eric Lefkofsky, CEO of ...